Authors:
Chalmers, D
Ferrand, C
Apperley, JF
Melo, JV
Ebeling, S
Newton, I
Duperrier, A
Hagenbeek, A
Garrett, E
Tiberghien, P
Garin, M
Citation: D. Chalmers et al., Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene, MOL THER, 4(2), 2001, pp. 146-148
Authors:
de Weerdt, O
van de Donk, NWCJ
Veth, G
Bloem, AC
Hagenbeek, A
Lokhorst, HM
Citation: O. De Weerdt et al., Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma, NETH J MED, 59(2), 2001, pp. 50-56
Authors:
Buijs, A
Poddighe, P
van Wijk, R
van Solinge, W
Borst, E
Verdonck, L
Hagenbeek, A
Pearson, P
Lokhorst, H
Citation: A. Buijs et al., A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies, BLOOD, 98(9), 2001, pp. 2856-2858
Authors:
Broeks, A
Russell, NS
Floore, AN
Urbanus, JHM
Dahler, EC
van't Veer, MB
Hagenbeek, A
Noordijk, EM
Crommelin, MA
van Leeuwen, FE
van't Veer, LJ
Citation: A. Broeks et al., Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations, INT J RAD B, 76(5), 2000, pp. 693-698
Citation: Hm. El-beltagi et al., Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide ordaunomycin are equally sensitive to the drug acetyldinaline as the parental cell line, LEUKEMIA, 14(1), 2000, pp. 213-214
Authors:
van Leeuwen, FE
Klokman, WJ
van't Veer, MB
Hagenbeek, A
Krol, ADG
Vetter, UAO
Schaapveld, M
van Heerde, P
Burgers, JMV
Somers, R
Aleman, BMP
Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497
Citation: Acm. Martens et A. Hagenbeek, Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia, EUR J CANC, 35(4), 1999, pp. 634-640
Authors:
Shipp, MA
Abeloff, MD
Antman, KH
Carroll, G
Hagenbeek, A
Loeffler, M
Montserrat, E
Radford, JA
Salles, G
Schmitz, N
Symann, M
Armitage, JO
Coiffier, B
Philip, T
Citation: Ma. Shipp et al., International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury, ANN ONCOL, 10(1), 1999, pp. 13-19
Authors:
Cheson, BD
Horning, SJ
Coiffier, B
Shipp, MA
Fisher, RI
Connors, JM
Lister, TA
Vose, J
Grillo-Lopez, A
Hagenbeek, A
Cabanillas, F
Klippensten, D
Hiddemann, W
Castellino, R
Harris, NL
Armitage, JO
Carter, W
Hoppe, R
Canellos, GP
Citation: Bd. Cheson et al., Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, J CL ONCOL, 17(4), 1999, pp. 1244-1253
Authors:
Shipp, MA
Abeloff, MD
Antman, KH
Carroll, G
Hagenbeek, A
Loeffler, M
Montserrat, E
Radford, JA
Salles, G
Schmitz, N
Symann, M
Armitage, JO
Philip, T
Coiffier, B
Citation: Ma. Shipp et al., International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury, J CL ONCOL, 17(1), 1999, pp. 423-429
Authors:
Vellenga, E
van Putten, WLJ
Boogaerts, MA
Daenen, SMGJ
Verhoef, GEG
Hagenbeek, A
Jonkhoff, AR
Huijgens, PC
Verdonck, LF
van der Lelie, J
Schouten, HC
Gmur, J
Wijermans, P
Gratwohl, A
Hess, U
Fey, MF
Lowenberg, B
Citation: E. Vellenga et al., Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?, BONE MAR TR, 23(12), 1999, pp. 1279-1282
Authors:
Arkesteijn, G
Jumelet, E
Hagenbeek, A
Smit, E
Slater, R
Martens, A
Citation: G. Arkesteijn et al., Reverse chromosome painting for the identification of marker chromosomes and complex translocations in leukemia, CYTOMETRY, 35(2), 1999, pp. 117-124
Authors:
Rozemuller, H
Terpstra, W
Rombouts, EJC
Lawler, M
Byrne, C
FitzGerald, DJP
Kreitman, RJ
Wielenga, JJ
Lowenberg, B
Touw, IP
Hagenbeek, A
Martens, ACM
Citation: H. Rozemuller et al., GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF, LEUKEMIA, 12(12), 1998, pp. 1962-1970
Authors:
Havenga, MJE
Vogels, R
Braakman, E
Kroos, N
Valerio, D
Hagenbeek, A
van Es, HHG
Citation: Mje. Havenga et al., Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences, GENE, 222(2), 1998, pp. 319-327